USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| May 6, 2022 (est) | Mar 31, 2022 | $-0.68 | $-0.55 | $-0.28 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| May 6, 2022 (est) | Mar 31, 2022 | $9.19M | $12.21M | $25.60M |
Cellectis's next estimated earnings date (based on same quarter last year's date) is May 6, 2022 for the fiscal quarter ending Mar 31, 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 9 | $-0.62 | $-0.97 | $-0.20 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 10 | $-2.70 | $-4.07 | $-1.09 |
| Dec 2023 | 9 | $-2.35 | $-4.87 | $-1.03 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 4 / 0 | $-0.73 | $-0.95 | $-0.94 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 6 / 0 | $-2.81 | $-3.23 | $-3.22 |
| Dec 2023 | 4 / 0 | $-2.52 | $-3.26 | $-3.24 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 3 | $9.56M | $1.11M | $15.50M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 9 | $45.47M | $6.67M | $74.50M |
| Dec 2023 | 9 | $84.89M | $10.80M | $183.58M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 3, 2022 | Dec 2021 | $-0.92 | $-0.55 | 40.22% |
| Nov 4, 2021 | Sep 2021 | $-0.86 | $-0.82 | 4.24% |
| Aug 5, 2021 | Jun 2021 | $-0.73 | $-0.88 | -21.38% |
| May 6, 2021 | Mar 2021 | $-0.81 | $-0.28 | 65.49% |
| Mar 4, 2021 | Dec 2020 | $-0.80 | $-0.95 | -18.38% |
| Nov 5, 2020 | Sep 2020 | $-0.61 | $-0.71 | -15.77% |
| Aug 5, 2020 | Jun 2020 | $-0.74 | $-0.76 | -2.70% |
| May 6, 2020 | Mar 2020 | $-0.65 | $0.47 | 172.43% |
| Mar 4, 2020 | Dec 2019 | $-0.74 | $-0.88 | -19.73% |
| Nov 6, 2019 | Sep 2019 | $-0.80 | $-0.38 | 52.74% |
| Aug 6, 2019 | Jun 2019 | $-0.60 | $-0.79 | -31.67% |
| May 7, 2019 | Mar 2019 | $-0.66 | $-0.36 | 45.45% |
| Mar 11, 2019 | Dec 2018 | $-0.72 | $-0.53 | 26.53% |
| Nov 13, 2018 | Sep 2018 | $-0.59 | $-0.54 | 8.47% |
| Aug 1, 2018 | Jun 2018 | $-0.58 | $-0.17 | 70.76% |
| May 7, 2018 | Mar 2018 | $-0.62 | $-0.71 | -13.91% |
| Mar 12, 2018 | Dec 2017 | $-0.68 | $-0.76 | -11.63% |
| Nov 13, 2017 | Sep 2017 | $-0.58 | $-0.73 | -26.96% |
| Aug 2, 2017 | Jun 2017 | $-0.59 | $-0.81 | -37.70% |
| May 9, 2017 | Mar 2017 | $-0.61 | $-0.58 | 6.12% |
| Mar 6, 2017 | Dec 2016 | $-0.34 | $-0.37 | -9.62% |
| Nov 22, 2016 | Sep 2016 | $-0.63 | $-0.38 | 39.65% |
| Sep 8, 2016 | Jun 2016 | $-0.42 | $-0.20 | 51.23% |
| May 11, 2016 | Mar 2016 | $-0.51 | $-0.96 | -90.00% |
| Mar 14, 2016 | Dec 2015 | $0.24 | $0.26 | 4.71% |
| Nov 19, 2015 | Sep 2015 | $-0.30 | $-0.40 | -33.33% |
| Sep 9, 2015 | Jun 2015 | $-0.36 | $-0.63 | -75.00% |
| Jun 9, 2015 | Mar 2015 | $-0.04 | $0.26 | 750.00% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 3, 2022 | Dec 2021 | $-2.95 | $-2.53 | - |
| Mar 4, 2021 | Dec 2020 | $-1.80 | $-1.95 | - |
| Mar 4, 2020 | Dec 2019 | $-2.25 | $-2.41 | - |
| Mar 11, 2019 | Dec 2018 | $-1.97 | $-1.95 | - |
| Mar 12, 2018 | Dec 2017 | $-2.99 | $-2.87 | - |
| Mar 6, 2017 | Dec 2016 | - | $-1.92 | - |
| Mar 14, 2016 | Dec 2015 | - | $-0.51 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 3, 2022 | Dec 2021 | $8.72M | $12.21M | 1.40% |
| Nov 4, 2021 | Sep 2021 | $11.43M | $8.31M | 0.73% |
| Aug 5, 2021 | Jun 2021 | $14.62M | $11.18M | 0.76% |
| May 6, 2021 | Mar 2021 | $7.80M | $25.60M | 3.28% |
| Mar 4, 2021 | Dec 2020 | $7.64M | $13.91M | 1.82% |
| Nov 5, 2020 | Sep 2020 | $10.79M | $9.24M | 0.86% |
| Aug 5, 2020 | Jun 2020 | $4.35M | $4.62M | 1.06% |
| May 6, 2020 | Mar 2020 | $16.23M | $4.62M | 0.28% |
| Mar 4, 2020 | Dec 2019 | $4.95M | $4.43M | 0.90% |
| Nov 6, 2019 | Sep 2019 | $3.28M | $8.49M | 2.59% |
| Aug 6, 2019 | Jun 2019 | $3.85M | $1.15M | 0.30% |
| May 7, 2019 | Mar 2019 | $4.45M | $3.43M | 0.77% |
| Mar 11, 2019 | Dec 2018 | $0.00 | $869.00K | - |
| Nov 13, 2018 | Sep 2018 | $8.66M | $905.00K | 0.10% |
| Aug 1, 2018 | Jun 2018 | $9.37M | $5.05M | 0.54% |
| May 7, 2018 | Mar 2018 | $8.93M | $8.06M | 0.90% |
| Mar 12, 2018 | Dec 2017 | $10.31M | $5.77M | 0.56% |
| Nov 13, 2017 | Sep 2017 | - | $6.12M | - |
| Aug 2, 2017 | Jun 2017 | - | $6.75M | - |
| May 9, 2017 | Mar 2017 | - | $6.77M | - |
| Mar 6, 2017 | Dec 2016 | - | $5.68M | - |
| Nov 22, 2016 | Sep 2016 | - | $11.32M | - |
| Sep 8, 2016 | Jun 2016 | - | $17.60M | - |
| May 11, 2016 | Mar 2016 | - | $7.95M | - |
| Mar 14, 2016 | Dec 2015 | - | $28.76M | - |
| Nov 19, 2015 | Sep 2015 | - | $8.55M | - |
| Sep 9, 2015 | Jun 2015 | - | $8.22M | - |
| Jun 9, 2015 | Mar 2015 | - | $9.05M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 3, 2022 | Dec 2021 | $62.33M | $57.29M | -8.08% |
| Mar 4, 2021 | Dec 2020 | $73.43M | $73.95M | 0.71% |
| Mar 4, 2020 | Dec 2019 | $21.62M | $22.99M | 6.34% |
| Mar 11, 2019 | Dec 2018 | $21.43M | $21.43M | 0.00% |
| Mar 12, 2018 | Dec 2017 | $39.33M | $33.72M | -14.28% |
| Mar 6, 2017 | Dec 2016 | - | $53.77M | - |
| Mar 14, 2016 | Dec 2015 | - | $55.04M | - |
CLLS's next estimated earnings date (based on same quarter last year's report date) is May 6, 2022 for the fiscal quarter ending Mar 31, 2022.
Cellectis's previous earnings date was Mar 3, 2022 for its fiscal quarter ended Dec 31, 2021.
CLLS's earnings per share (EPS) was $-0.55, beating the consensus analysts forecast of $-0.92 by 40.22%.
The EPS was higher than the previous fiscal quarter (Sep 2021) by -32.93%, and higher than the same period a year before (Dec 2020) by -42.11%.
Revenues were $12.21M, better than the forecast of $8.72M by 39.97%, up by 46.84% from the previous quarter , and down by -12.27% from the same period last year.
The company reported a net income of $-25.00M.Free cash flow for the quarter was $-21.69M , compared to $-35.90M last quarter and $-51.88M a year before.
CLLS ended the quarter with $100.87M in total debt, a decrease of -2.34% compared to the previous quarter, and an increase of 183.89% compared to the same quarter a year before.
Cellectis's previous annual earnings date was Mar 3, 2022 for its fiscal year ended Dec 31, 2021.
CLLS's earnings per share (EPS) was $-2.53, beating the consensus analysts forecast of $-2.95 by -14.24% , and lower than the previous year's EPS (Dec 2020) by 29.74%.
Revenues were $57.29M, worse than the forecast of $62.33M by -8.08%, and down by -22.52% from previous year's revenue.
The company reported a net income of $-114.20M.
Cellectis reported a free cash flow of $-124.31M for its fiscal year, compared to $-126.52M a year ago.
The company ended the fiscal year with $100.87M in total debt, an increase of 183.89% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
